This paper presents a hybrid simulation model for the management of an eye condition called age-related macular degeneration, which particularly affects the elderly. The model represents not only the detailed clinical progression of disease in an individual, but also the organization of the hospital clinic in which patients with this condition are treated and the wider environment in which these patients live (and their social care needs, if any, are met). The model permits a 'whole system' societal view which captures the interactions between the health and social care systems.
There are many forms of AMD, although they are broadly grouped as being either 'wet' and 'dry', with 'wet' AMD consisting of between 65-70% of the total disability burden (Minassian et al. 2011) . The 'dry' form of AMD is irreversible and is characterized by a slow transition to impairment, while the 'wet' form results in more rapid visual deterioration. However it can usually be treated using injections of ranibizumab which slows the impairment or even causes vision to improve (Lotery 2008) . These injections need to be given at regular monthly intervals in order to show benefit to the patient. This is a new treatment and many hospital eye units do not have the organizational structure nor the capacity to manage the regular need for injections or consulting. Appointment booking systems are not efficient at managing this regular need for care.
The implications of visual impairment in general, and AMD in particular, are wide-ranging. Those with AMD are seen to be more likely to be depressed (Brody et al. 2001) , have a lower quality of life (Slakter and Stur 2005; Hassell et al. 2006 ) and less functional independence (Williams et al. 1998) . It is estimated that mild AMD causes a similar reduction in the quality of life as moderate cardiac angina (Brown et al. 2005) . The reduced vision interferes with the ability to self-care (Stevenson, Hart et al. 2004) , leading to increasing reliance on both formal (i.e., provided through an established channel) and informal (i.e., given by family or friends) social care. Without this care the individual may not be able to function on their own and require a higher level of health care for non-visual related health issues.
The Eye Unit at Southampton General Hospital is the sole treatment center for AMD in the UK county of Hampshire. It is currently providing injections for those with wet AMD but it is not felt that this is being conducted in the most efficient manner. Furthermore there is concern about the ability of the Unit to cope with the growing ageing population, which could potentially lead to a number of patients failing to receive the care that they require, increasing the social care burden. This paper focuses on the development and treatment of 'wet' AMD in the area served by the Southampton Eye Unit. Sufferers of the condition have related care needs, often complicated by other conditions due to the age-related nature of AMD. These needs may or may not be met through receiving social care, either formally (provided by the state or privately) or informally (provided by family and friends). Formal social care is determined after an assessment of need while informal care depends on the network of friends and family surrounding the individual. The social care obtained also links with the ease of travelling to Southampton General Hospital for treatment -those with little support will find this more difficult and may miss appointments leading to further deterioration of vision, enhancing the need for social care. The Eye Unit needs to be organized to allow treatment of the maximum numbers of patients without reducing the patient experience.
The study has been carried out in collaboration with the Southampton Eye Unit in order to explore alternative configurations of the clinic in the safety of a computer environment, including potential options such as mobile eye unit which perform time-consuming eye photography to alleviate pressure on shared facilities at the clinic. Through exploring different potential configurations of care given at the Eye Unit, changes in the efficiency of the Unit can be estimated as well as the corresponding improvements in health and reductions in the need for social care. Ultimately, the work also aims to highlight how expenditure in one area (health or social care) may cause non-obvious cost implications in the other (e.g., improved social care transport services saving considerable amounts in the clinic due to less missed appointments, and with knock-on savings in social care due to less avoidable AMD sight loss). Figure 1 illustrates the conceptual architecture of the model, which is not yet fully realized in the current implementation (section 3) but guides the work. DES and SD components sit inside an overarching agentbased model. Individuals (agents) in the population may develop AMD, alongside other conditions, and have varying levels of care need. Some may provide informal care to others. Embedded SD models in each individual model progressive sight loss from AMD and other conditions. Individuals with eye conditions (not just AMD) will interact with the healthcare system via the ophthalmology department and, potentially, mobile units. The clinic is modeled as a DES with explicit appointment scheduling processes.
METHODOLOGY
Doctors interact with this clinic, and may respond to scheduling pressures (e.g., by adjusting the slots in their timetables for different conditions).
Interactions occur in a spatial environment, which can be used to model aspects such as ability to travel to the clinic, the location of those providing care to AMD sufferers (which influences their ability to provide care), and the positioning of mobile eye units. The hybridization in the model here can be seen as an elaborate combination of "processenvironment" type combinations (Chahal and Eldabi 2008) , if their focus on DES and SD is relaxed to include ABM. Sub-models sit inside other models, with the inner model representing a process which interacts with the wider system environment of the outer model. A similar approach was used in the two illustrative examples of Brailsford et al. (2010) . In Swinerd and McNaught's terminology for ABM and SD hybrids (2012) , the model uses flavors of their "integrated" hybrid design alternative (cf. "interfaced" or "sequential"), with a similar need to relax the specific focus.
he modeling here is primarily motivated by using the best combination of tools, rather than any claim of novel hybridization. By 'best', we mean using the modeling paradigm which most cleanly implements the conceptual design we had in mind for each sub-system. This is discussed per sub-system in section 3. By combining the different methodologies which are best suited for their particular tasks, the stakeholders have gained greater buy-in and understanding, where the stakeholders include both the problem owners (health care and social care professionals) and those members of the project team who are unfamiliar with the techniques. In technical terms, the modeling framework used (AnyLogic) natively provides constructs with which to link the paradigms; some simple additional 'plumbing' code was still needed to allow agents to pass through the DES wrapped in a DES entity object.
Stakeholder Interaction
The model was developed with input from staff at the Eye Unit, but not in a fully stakeholder-driven process. The DES models the clinic at a fine-grained time resolution, but the long-term effects of treatments on sight loss are also of interest, particularly with feedback effects due to changes in social care and its influence on missed injections. These long timescales mean that assumptions have to be made about what is subject to change and what can be regarded as static. The emphasis therefore has to be on presenting challenging 'what-if' scenarios, and not 'best guess' projections or predictions.
Scenarios
There are a wide range of potential 'what-if' scenarios that could be explored within this conceptual framework. In general, the clinic DES model (section 3.2) and sight loss SD models ( section 3.3) can be used to explore health care scenarios, and the agent-based elements (section 3.4) to explore social care scenarios. The social care consequences can be evaluated in terms of health care scenarios, and vice versa. Examples of potential scenarios which could be evaluated are shown in Table 1 . Patient pathways, opening times, appointment times, availability of resources both staff and medical facilities for example.
Social care need
Changing development rates for varying levels of care need in relation to age, and the specific impact of AMD on these rates.
Sight loss and AMD Stages
Differing models of sight deterioration (both natural and AMD), and the effects of differing treatments (including individual heterogeneity in response).
Social care provision
Changes in the patterns of care provided to those in need (both level and type).
For the current paper the aim is to demonstrate the interconnectedness between the health and social care systems, highlighting how changes in one sphere can result in changes to the other. Four different scenarios are therefore investigated, representing: the current situation, changes to the healthcare supply, changes to the social care supply, and a combination of the two. These will be fully explained in section 4.2.
DETAILS OF THE MODEL
The current model represents a stepping-stone towards the full aspirations highlighted in section 2. Most areas have been parameterized with accurate data from various sources, the main ones being: the English Longitudinal Study of Ageing (ELSA 2012) The model is implemented in AnyLogic (www.xjtek.com/AnyLogic), a commercial package that supports the integration of DES, SD and agent-based models, with features for each comparable to paradigm-specific products.
Overall Structure
Individuals develop AMD, and will then interact with the DES that represents the eye clinic via appointments (see Figure 2) . On an initial AMD diagnosis, the individual (agent) is scheduled for an initial appointment and stores this information, effectively setting up an event for the appointment time. The patient then attends the appointment, at which point it interacts with the eye clinic DES. After the appointment is finished the agent leaves the DES model and the next appointment, which may be either a follow-up or an injection appointment, is scheduled This scheduling currently uses some simplifying assumptions about the number and duration of available slots, but still captures the essence of the real-life mechanism. This dynamic cycle of appointments continues until other events, such as death, intervene. The treatment that the individual may or may not receive impacts the progression of his/her sight loss in the agent-embedded SD models. Individuals can miss appointments for a variety of reasons (such as transport difficulties, illness or simply through forgetfulness) and can fail to complete appointments (generally due to excessive queues in the clinic, or due to insufficiently flexible transport arrangements). In both cases, an injection is missed which will cause avoidable sight deterioration. These are the main mechanisms by which social care issues can influence the clinic's operation. Missed appointments are modeled as probabilities based on the individual's care need and the type of care received (where need and provision levels map to multipliers applied to a basic fixed probability of missing the appointment). Incomplete appointments are modeled as probabilities based on time spent queuing. These parameters are currently based on expert opinion, but there is potential to use empirical data to improve them.
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Eye Clinic DES Model
The choice of DES to model the Eye Unit is natural to simulate the detailed processes and layout of the system. Clearly this is unique to the context, but in overall structure and concept it is a standard DES outpatient clinic model in a long tradition of such queuing network type models. Jun et al. (1999) present a survey of 117 such clinic models, although obviously not all for eye conditions, and this is a classical application area for DES in health. DES has also been applied, unusually, for modeling the clinical progression of eye disease by Davies et al. (2000; , in order to evaluate the effectiveness of different screening policies for diabetic retinopathy. The approach most typically used to model clinical progression in economic evaluations of interventions is either Markov modeling or decision tree analysis (Cooper, Brailsford and Davies 2007) . In the specific case of AMD, there are a small number of published models which use models to study the cost-effectiveness or cost-utility of different drugs, for example Fletcher et al. (2008) , but none that use DES.
Staff from the clinic have been involved in the conceptualization of the model, helping to define the patient pathways and physical layout of the clinic. AnyLogic allows the entities to be modeled physically moving through the clinic space as they go through the steps of the pathway. The results shown here use modeler estimates for the parameters. The clinic is hoping to make internal tracking data available soon, which can be used to derive more empirically-driven values. A patient questionnaire will also be incorporated to aid the parameterization of the patients' behavior outside the clinic, such as their mode of transport to the clinic, who accompanied them to the clinic and care relationships.
Full details of the DES model structure and data are available on our project Web site at http://www.soton.ac.uk/clc/publications/supplementary.
Sight Loss and AMD Progression (State-Transition and Embedded SD Models)
The process of sight loss, both natural and AMD-related, lends itself to a rate-based mathematical representation which SD models are ideal for. (In our case, 'natural' could conceptually include other non-AMD eye conditions.) Sight level is modeled very simply as a stock which is decreased via natural and AMD loss rates. The progression of AMD itself is modeled by a simple set of stochastic stage transitions (using AnyLogic statecharts), where the stages cause changes in the AMD-related sight-loss rate. AMD does not affect each eye identically. As a result, sight loss progresses differently in each eye and hence each agent actually has a pair of SD models (one for each eye), each parameterized separately. Figure 3 shows a schematic of the SD model used for the left eye; the model for the right eye is the same. Obtaining an injection will slow the AMD-related degeneration of sight (Lotery 2008 ). There is individual heterogeneity, both for each eye and between individuals, including in their reaction to injections and the 'virulence' of their AMD. Future work will align this sub-model more explicitly with specific clinical details of sight loss and AMD progression (e.g., Klein et al. 2002; Owen et al. 2012 ).
Individual Care, Mortality and AMD Development
Conceptually (as described in Figure 1) , the model has a full population of individuals who will develop AMD and form care relationships. Implementing this in an empirically accurate way via explicit, endogenous agent behavior is a major challenge, and is an area of research in its own right. (It is typically done via regression-model-driven microsimulation, but see Noble et al. (2012) for other approaches being considered on the CLC project.) To simplify matters, the current model abstracts away this detail. Only AMD-suffering individuals are explicitly included in the population, and are created synthetically based on current numbers of new patients, with incidence data used to set initial attributes such as age and gender. (These therefore represent patients already referred.) Dynamically changing care needs are modeled using statecharts, with the type of care provided stochastically derived from care need level. Transitions are based on cross-tabulated population-level statistics. An individual's AMD progression is linked to care need by having sight-level categories imposing a minimum level of care need (with some stochastic variation). Mortality is based on population-level age-dependent life tables, with per-year checks, and is a significant factor since at least 30% of AMD diagnoses are for 90+ year-olds.
The accuracy of these parameters is currently limited by the fact that population-level data should ideally be adjusted so that it reflects distributions for AMD-sufferers in particular. This is still work in progress.
Current Output Measures
The current main output measures available from the model are as below:
Medical (DES)
Health and Social (ABM, SD) Length of stay in the clinic.
AMD-suffering population size and mortality. Numbers of missed injections (due to missed appointments or leaving appointments early).
AMD stage distribution in the population.
Numbers of patients treated and quality criteria for timeliness of appointments.
Care provision types distribution in the population. Utilization of Ophthalmology resources (rooms, staff, waiting areas, etc.).
Sight level distribution in the population.
Care need level distribution in the population.
EXPERIMENTATION
As discussed in section 2.2, four 'what-if' scenarios were run in the current model to explore the interconnectedness of the health and social care systems. For the purposes of this paper, the number of missed injections was chosen as the main output measure for discussion (see section 4.3), since this is a rough proxy both for the efficiency of the healthcare system and the effectiveness of care provision in the community. This exploration was originally intended to include extensive analysis of and the sensitivity of several outcome measures to key parameters, as well as using an initial and ongoing AMD-suffering population that matched the clinic's current levels: around 1600 'AMD eyes', which thus maps to 800-1600 individuals and, at least at some stages, 20 new patients a week. Run lengths of 30 years were planned so that the longer-term dynamics of sight loss and ageing could be explored. Unfortunately, even with considerable performance tuning, models with only 50 initial individuals and 2 new patients a week (on average) would take over 28 hours to run 15 simulated years on a relatively high specification system (AMD Phenom II at 3.1GHz).
The current results are therefore scaled back to representative runs for 1 simulated year for each scenario, with 50 initial individuals and 2 new patients a week. The original analysis can hopefully be performed in future, via further performance tuning and/or increased computing resources and timescales.
Scenarios Tested
These are: 1. Base -The Eye Unit appointment system and organization remains as it currently is for the entire simulation duration. Data for the other health and social aspects of the model remain constant, drawn from the literature, data analysis of surveys, expert opinion and educated guesses. This is the scenario against which all others will be compared.
2. Healthcare -In this scenario an additional Optical Coherence Tomography (OCT) machine is installed in the Eye Unit. After initial analysis and discussions with clinical members of the Unit, it was observed that this is the key area where current bottlenecks are observed in the system. 3. Social care -As not all individuals who need social care currently receive it, this scenario simulates some nominal care provision stimulus. Individuals have a 50% chance of receiving one 'level' better care than they would have previously, where the care provision types None, Informal, Formal and Both are viewed as an increasing sequence of levels (and with increasingly less negative effects on the likelihood of missing clinic appointments).
4. Healthcare and Social Care -this scenario combines scenarios 2 and 3 above.
Results
The results from single representative runs are shown in Figure 1 . They suggest that improving the Eye Unit's capability by increasing the number of OCT machines results in more patients successfully completing their appointments, as fewer patients leave the department who have waited an excessive amount of time. Increasing the amount of social care also has a positive effect when compared with the base, with more patients being able to attend their appointments. What is somewhat counterintuitive at this stage is that the combined scenario leads to less reduction in numbers of missed appointments over time than the individual scenarios on their own. A possible explanation for this is that the increased appointment attendance from the social care scenario places more pressure on the clinic than the extra OCT (healthcare scenario) can alleviate. Thus, reduced missed appointments are outweighed by increased incomplete appointments. 
FUTURE WORK
Future areas of work have been hinted at in the conceptual design ( figure 1 ) and in the detail of the model and current results. These fall into the following broad categories:
• performance analysis of the model and the underlying AnyLogic platform;
• better quality data, reflecting the distributional specifics of the AMD-suffering population;
• more accurate demographic processes (e.g., factoring in demographic change to the number of new AMD cases); • a more empirically-validated sight loss sub-model, with related quality-adjusted life year (QALY) style metrics for avoidable sight-years lost due to system inefficiencies; • more accurate reflection of the appointment scheduling process used;
• adding more nuanced detail of links between health and social care (e.g., inflexible hospitalprovided transport causing patients to have to leave appointments early, and better alignment of AMD progression with care need); • increased spatiality, especially as regards scenarios for mobile eye-photography units;
• more 'ABM-like' explicit agent behavior, both for individuals in the population and doctors at the clinic, which can endogenously generate patterns of care provision and the like; • estimates of the resultant impacts on costs in both the health and social care sectors (which will involve additional stakeholders).
CONCLUSIONS
This work has created a useful whole system modeling framework for health and social care. The aim of the CLC project is to take this whole system view, looking at each of the quadrants in Figure 5 . There are many links between each of these areas, and this model has highlighted some of these for one disease (AMD). Focusing on a single disease has helped reduce the inevitable complexity, but the generality of some of the concepts and design suggests extensions beyond AMD. The project aims to use the right tools for the job (particularly ideas from complexity science) to demonstrate and understand the interactions and feedback between health and social care. The model here uses different components, constructed for specific purposes, which are then combined into a complete model. As a result it is easier to discuss it with stakeholders as they can focus on the area that is of most interest to them. More generally, stakeholders can get 'traditional' OR advice on operational improvements whilst emphasizing the broader societal context, especially the sometimes-subtle effects of healthcare decisions on social care (and vice versa). This will be particularly useful going forwards, since the longer-term aim is to involve budget-holding stakeholders from health and social care, allowing them to see the broader implications and mutuality of their decisions. In England, the health and social care budgets are currently totally separate. Healthcare is funded by the taxpayer: it is provided by the National Health Service (NHS) and is free to the patient at the point of delivery. On the other hand, social care is provided by several different sources: informal care provided unpaid by family members or friends, and formal care provided either by the local county authority where the person lives, the private sector, or the voluntary sector. This model demonstrates the politics involved in a situation where relatively short-term expenditure by the NHS (e.g., providing an extra OCT machine in the clinic) can lead to longer-term cost savings for the local authority, since fewer people will go blind and require expensive residential care. Preventing avoidable sight loss in the elderly not only makes sense from a humanitarian perspective, it also makes sense from an economic perspective. However, without a whole system model which takes a societal perspec-tive, it is difficult to see why the NHS should bear the entire cost. The model provides a mechanism to explore such trade-offs.
The integration of DES, ABM and SD in a health care context is rare. This study adds to the knowledge base regarding the benefits of doing this, alongside the issues regarding truly integrated models -the 'holy grail'. The main conceptual difficulties lie in designing sub-components and their interactions so that they represent the real-world complexity without overwhelming the model with impenetrable detail. This process is both enriched and made more challenging by the combination of disciplines involved. The work required a marriage of an OR stakeholder-driven approach, with the 'empirical eye' of social statisticians and the micro-level theories of complexity science. Social statistics helped make informed decisions on where mechanisms could be abstracted from relationships in empirical data, rather than having the causal mechanisms modeled explicitly. However, the latter is a strong current in complexity science, and promises to help in better modeling individuals' adaptation to changing social and technological contexts, which the scenarios explored here represent. Future work may therefore move further towards this style of theory-driven modeling, à la Noble et al. (2012) .
